GRANULES PHARMS FDA Approval ANDA 213306

ANDA 213306

GRANULES PHARMS

FDA Drug Application

Application #213306

Application Sponsors

ANDA 213306GRANULES PHARMS

Marketing Status

Prescription001

Application Products

001FOR SOLUTION;ORAL50MG/ML0VALGANCICLOVIR HYDROCHLORIDEVALGANCICLOVIR HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2020-01-31STANDARD
LABELING; LabelingSUPPL3AP2022-06-29STANDARD

Submissions Property Types

ORIG1Null7
SUPPL3Null15

TE Codes

001PrescriptionAB

CDER Filings

GRANULES PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 213306
            [companyName] => GRANULES PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"VALGANCICLOVIR HYDROCHLORIDE","activeIngredients":"VALGANCICLOVIR HYDROCHLORIDE","strength":"50MG\/ML","dosageForm":"FOR SOLUTION;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"01\/31\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-01-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.